After Hours Gainer
HCWB HCW Biologics10.05+4.84+92.9%
After Hours:11.72+1.67 (+16.6%)
HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Globe NewswireTue, 13-May 8:01 PM
Premarket Gainer
HCWB HCW Biologics2.92+0.22+8.2%
Premarket:7.42+4.50 (+154.1%)
HCW Biologics Receives FDA Clearance to Proceed with Phase 1b Clinical Trial for Immunotherapeutic HCW9218 for Pancreatic Cancer
Globe NewswireThu, 28-Oct 7:00 AM
